Nectar Lifescience Key Ratios
NSE: NECLIFE | BSE: 532649
₹9.81
As on 20-Nov-2026IST
Market cap
₹192 Cr
Revenue (TTM)
₹2 Cr
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -97.51 | -98.46 | 138.11 | -89.54 | -74.03 |
| EBIT | 75.22 | -1,645.79 | -51,259.89 | -262.80 | -207.12 |
| Net Profit | 122.67 | 1,075.91 | -872.11 | -17.07 | 11.94 |
| EPS | 117.69 | 101.79 | 78.21 | -397.84 | -23.36 |
| Book Value | -- | -- | -29.69 | -14.21 | -8.74 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 5.39 | 3.69 | -5,362.88 | -- | -- |
| Net Margin
| 0.29 | 0.08 | 71.12 | -- | -- |
| Return on equity
| -2.31 | -1.37 | -0.69 | -7.46 | 0.07 |
| Return on Capital
| 0.65 | 2.05 | -- | -4.75 | 0.59 |
| Return on Assets
| -1.51 | -0.91 | 1.51 | -4.80 | 0.03 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.00 | 0.61 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
--
|
-4.75
|
0.59
|
6.12
|
2.49
|
|
Peer Median
|
--
|
12.41
|
16.46
|
15.49
|
--
|
ROE
-0.69
Lower than Peers by 9.77
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
-0.69
|
-7.46
|
0.07
|
0.47
|
-2.25
|
|
Peer Median
|
9.08
|
13.36
|
13.87
|
14.72
|
--
|
ROA
1.51
Lower than Peers by 5.76
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
1.51
|
-4.80
|
0.03
|
0.23
|
-1.06
|
|
Peer Median
|
7.27
|
7.23
|
8.04
|
7.19
|
--
|
EBIT Margin
-5,362.88
Lower than Peers by 5,372.13
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
-5,362.88
|
--
|
--
|
5.39
|
-0.40
|
|
Peer Median
|
9.25
|
17.33
|
10.05
|
10.28
|
--
|
Net Margin
71.12
Higher than Peers by 62.66
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
71.12
|
-538.87
|
6.70
|
0.29
|
-1.53
|
|
Peer Median
|
8.46
|
11.16
|
9.11
|
6.78
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
0.00
|
--
|
--
|
3.41
|
2.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
138.11
Higher than Peers by 131.48
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
138.11
|
--
|
-100.00
|
10.53
|
-8.70
|
|
Peer Median
|
6.64
|
26.57
|
7.17
|
10.56
|
--
|
EBIT Growth
-51,259.89
Lower than Peers by 51,259.58
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
-51,259.89
|
-7,473.82
|
-100.89
|
1,586.17
|
-106.02
|
|
Peer Median
|
-0.31
|
31.63
|
12.05
|
6.17
|
--
|
Net Profit Growth
-872.11
Lower than Peers by 879.69
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
-872.11
|
-8,327.69
|
-86.05
|
120.66
|
-196.55
|
|
Peer Median
|
7.58
|
26.27
|
22.15
|
27.97
|
--
|
EPS Growth
78.21
Higher than Peers by 77.12
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
78.21
|
-197.43
|
-2,376.25
|
120.65
|
-196.54
|
|
Peer Median
|
1.08
|
24.54
|
8.80
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
--
|
-39.10
|
-10.58
|
0.44
|
-2.14
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
--
|
--
|
0.61
|
0.59
|
0.71
|
|
Peer Median
|
0.02
|
0.17
|
0.03
|
0.05
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
--
|
--
|
0.46
|
0.39
|
0.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
11.64
Higher than Peers by 9.24
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
11.64
|
9.71
|
1.21
|
1.32
|
1.38
|
|
Peer Median
|
2.40
|
2.09
|
2.20
|
1.93
|
--
|
Quick Ratio
11.64
Higher than Peers by 9.93
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
11.64
|
9.70
|
0.54
|
0.59
|
0.63
|
|
Peer Median
|
1.71
|
1.62
|
1.72
|
1.59
|
--
|
Interest Coverage
0.51
Lower than Peers by 9.28
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
0.51
|
-1.34
|
1.13
|
1.20
|
0.53
|
|
Peer Median
|
9.79
|
10.26
|
12.28
|
12.45
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
--
|
--
|
--
|
22.52
|
18.35
|
|
Peer Median
|
27.04
|
32.97
|
26.23
|
23.97
|
--
|
Asset Turnover
0.00
Lower than Peers by 0.69
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
0.00
|
--
|
--
|
0.89
|
0.77
|
|
Peer Median
|
0.69
|
0.65
|
0.74
|
0.88
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
--
|
--
|
--
|
62.43
|
75.92
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
--
|
--
|
--
|
130.94
|
139.23
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
--
|
--
|
--
|
112.09
|
109.47
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
--
|
--
|
--
|
81.28
|
105.68
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-19.21
Lower than Peers by 59.91
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
-19.21
|
--
|
--
|
135.18
|
--
|
|
Peer Median
|
40.70
|
41.20
|
39.17
|
40.74
|
--
|
Price / Book Value
0.34
Lower than Peers by 3.26
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
0.34
|
0.31
|
0.54
|
0.63
|
0.33
|
|
Peer Median
|
3.60
|
4.48
|
3.61
|
3.87
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.10
|
0.10
|
0.19
|
0.20
|
--
|
EV/EBITDA
-1.11
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
-1.11
|
-1.37
|
105.53
|
7.66
|
10.30
|
|
Peer Median
|
--
|
38.53
|
28.79
|
25.41
|
--
|
Market Cap
192
Lower than Peers by 4,921
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Nectar Lifescience
|
192
|
--
|
--
|
675
|
356
|
|
Peer Median
|
5,114
|
5,114
|
3,944
|
2,959
|
--
|